Selective TNF Inhibition for Chronic Stroke and Traumatic Brain Injury: An Observational Study Involving 629 Consecutive Patients Treated with Perispinal Etanercept

No abstract is available for this paper.

• Publication year

  2012

• Venue

  CNS Drugs

• Publication date

  2012-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s40263-013-0057-yPMID 23580176PMCID PMC3668780
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• American Physical Therapy Association

  2014cited by this paper
• Author’s Reply to Page: “Selective TNF Inhibition for Chronic Stroke and Traumatic Brain Injury: An Observational Study Involving 629 Consecutive Patients Treated with Perispinal Etanercept”

  2013cited by this paper
• A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β

  2012cited by this paper
• Tumor Necrosis Factor-Induced Cerebral Insulin Resistance in Alzheimer's Disease Links Numerous Treatment Rationales

  2012cited by this paper
• Tell us how can we improve health outcomes for children.

  2012cited by this paper
• Mini-Mental State Examination versus Montreal Cognitive Assessment: rapid assessment tools for cognitive and functional outcome after aneurysmal subarachnoid hemorrhage.

  2012cited by this paper
• Evaluation of cognitive impairment by the Montreal Cognitive Assessment in patients with aneurysmal subarachnoid haemorrhage: prevalence, risk factors and correlations with 3 month outcomes

  2012cited by this paper
• TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation

  2012cited by this paper
• Patient experiences of bladder problems following stroke.

  2012cited by this paper
• Neurological Impairment Among Survivors of Intracerebral Hemorrhage: The FAST Trial

  2012cited by this paper
• Post-Ischemic Inflammation in the Brain

  2012cited by this paper
• Symptomatic and Palliative Care for Stroke Survivors

  2012cited by this paper
• Integrated safety analysis: short- and long-term safety profiles of etanercept in patients with psoriasis.

  2012cited by this paper
• Systemic and Central Immunity in Alzheimer's Disease: Therapeutic Implications

  2012cited by this paper
• Etanercept: efficacy and safety for approved indications

  2012cited by this paper
• New Hope for Survivors of Stroke and Traumatic Brain Injury

  2012cited by this paper
• Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise.

  2012cited by this paper
• Tumor necrosis factor-α synthesis inhibitor 3,6′-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer’s disease

  2012cited by this paper
• Tumor necrosis factors blocking agents: analogies and differences.

  2012cited by this paper
• Selective TNF Inhibition for Chronic Stroke and Traumatic Brain Injury

  2012cited by this paper
• Brain Protection from Stroke with Intravenous TNFα Decoy Receptor-Trojan Horse Fusion Protein

  2012cited by this paper
• Deciphering the physiology underlying the rapid clinical effects of perispinal etanercept in Alzheimer's disease.

  2012influential reference
• AMPA Receptor Trafficking in Homeostatic Synaptic Plasticity: Functional Molecules and Signaling Cascades

  2012cited by this paper
• Management of hemiplegic shoulder pain following stroke.

  2012cited by this paper
• Early Elevation of Serum Tumor Necrosis Factor-α Is Associated With Poor Outcome in Subarachnoid Hemorrhage

  2012cited by this paper
• Epidural Administration of Spinal Nerves With the Tumor Necrosis Factor-Alpha Inhibitor, Etanercept, Compared With Dexamethasone for Treatment of Sciatica in Patients With Lumbar Spinal Stenosis: A Prospective Randomized Study

  2012cited by this paper
• Effectiveness and Safety of Etanercept in Patients with Psoriatic Arthritis in a Canadian Clinical Practice Setting: The REPArE Trial

  2011cited by this paper
• Implications of Gliotransmission for the Pharmacotherapy of CNS Disorders

  2011cited by this paper
• Stroke patients who regain urinary continence in the first week after acute first‐ever stroke have better prognosis than patients with persistent lower urinary tract dysfunction

  2011cited by this paper
• The Mini-Mental State Examination and Montreal Cognitive Assessment in persons with mild subacute stroke: relationship to functional outcome.

  2011cited by this paper
• Anti-TNF-α reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains.

  2011cited by this paper
• Placebo interventions, placebo effects and clinical practice

  2011cited by this paper
• History of the Vertebral Venous Plexus and the Significant Contributions of Breschet and Batson

  2011cited by this paper
• Neuroprotection with a Brain-Penetrating Biologic Tumor Necrosis Factor Inhibitor

  2011cited by this paper
• Placebo effect studies are susceptible to response bias and to other types of biases.

  2011cited by this paper
• Early molecular and synaptic dysfunctions in the prodromal stages of Alzheimer’s disease: focus on TNF-α and IL-1β

  2011cited by this paper
• Targeting TNF-Alpha to Elucidate and Ameliorate Neuroinflammation in Neurodegenerative Diseases

  2011cited by this paper
• Assessment of long-term safety and efficacy of etanercept in a 5-year extension study in patients with rheumatoid arthritis.

  2011cited by this paper
• Stroke rehabilitation.

  2011cited by this paper
• Rapid Improvement of Chronic Stroke Deficits after Perispinal Etanercept

  2011cited by this paper
• Etanercept attenuates pain-related behavior following compression of the dorsal root ganglion in the rat

  2011cited by this paper
• Intrathecal Etanercept Partially Restores Morphine's Antinociception in Morphine-Tolerant Rats via Attenuation of the Glutamatergic Transmission

  2011cited by this paper
• An open-label, prospective cohort pilot study to evaluate the efficacy and safety of etanercept in the treatment of moderate to severe plaque psoriasis in patients who have not had an adequate response to adalimumab.

  2011cited by this paper
• Stroke and the immune system: from pathophysiology to new therapeutic strategies.

  2011cited by this paper
• Etanercept: effectiveness and safety data of a retrospective study

  2011cited by this paper
• Anti-TNF therapy in the injured spinal cord.

  2011cited by this paper
• Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease

  2011cited by this paper
• The Montreal Cognitive Assessment: Short Cognitive Evaluation in a Large Stroke Trial

  2011cited by this paper
• Etanercept Restores the Antinociceptive Effect of Morphine and Suppresses Spinal Neuroinflammation in Morphine-Tolerant Rats

  2011cited by this paper
• Clinical trial safety and mortality analyses in patients receiving etanercept across approved indications.

  2011cited by this paper
• Shaping plasticity to enhance recovery after injury.

  2011cited by this paper
• Pseudobulbar affect: the spectrum of clinical presentations, etiologies and treatments

  2011cited by this paper
• Perispinal etanercept: a new therapeutic paradigm in neurology

  2010influential reference
• Underestimation of Cognitive Impairment by Mini-Mental State Examination Versus the Montreal Cognitive Assessment in Patients With Transient Ischemic Attack and Stroke: A Population-Based Study

  2010cited by this paper
• Immediate anti‐tumor necrosis factor‐α (etanercept) therapy enhances axonal regeneration after sciatic nerve crush

  2010cited by this paper
• Placebo interventions for all clinical conditions.

  2010cited by this paper
• Comprar tPA for Stroke The Story of a Controversial Drug | Justin A. Zivin | 9780195393927 | Oxford University Press

  2010cited by this paper
• Therapeutic evaluation of etanercept in a model of traumatic brain injury

  2010influential reference
• Differential Activation of Tumor Necrosis Factor Receptors Distinguishes between Brains from Alzheimer's Disease and Non-Demented Patients

  2010cited by this paper
• The roles of TNF in brain dysfunction and disease.

  2010influential reference
• The Montreal Cognitive Assessment (MoCA) is superior to the Mini-Mental State Examination (MMSE) for the detection of vascular cognitive impairment after acute stroke.

  2010cited by this paper
• Soluble TNF receptors are associated with Aβ metabolism and conversion to dementia in subjects with mild cognitive impairment.

  2010cited by this paper
• Distribution and tumor necrosis factor-alpha isoform binding specificity of locally administered etanercept into injured and uninjured rat sciatic nerve.

  2009cited by this paper
• Inflammation and Anti-Inflammatory Strategies for Alzheimer’s Disease – A Mini-Review

  2009cited by this paper
• Randomized, Double-blind, Placebo-controlled, Dose-response, and Preclinical Safety Study of Transforaminal Epidural Etanercept for the Treatment of Sciatica

  2009cited by this paper
• Central post-stroke pain: clinical characteristics, pathophysiology, and management.

  2009cited by this paper
• Post-Stroke Cognitive Impairments

  2009cited by this paper
• Decreased behavioral impairments in an Alzheimer mice model by interfering with TNF-alpha metabolism.

  2009cited by this paper
• Effects of Etanercept and Minocycline in a rat model of spinal cord injury

  2009cited by this paper
• Rapid intracerebroventricular delivery of Cu-DOTA-etanercept after peripheral administration demonstrated by PET imaging

  2009cited by this paper
• The value of drug repositioning in the current pharmaceutical market.

  2009cited by this paper
• Perispinal etanercept for neuroinflammatory disorders.

  2009influential reference
• Tumour Necrosis Factor Modulation for Treatment of Alzheimer’s Disease

  2009cited by this paper
• Intranasal delivery of ESBA105, a TNF-alpha-inhibitory scFv antibody fragment to the brain.

  2009cited by this paper
• Motor recovery after stroke: a systematic review.

  2009cited by this paper
• Paths to acceptance

  2008cited by this paper
• Mechanisms of Microglia-Mediated Neurotoxicity in a New Model of the Stroke Penumbra

  2008influential reference
• The causes and treatment of pseudobulbar affect in ischemic stroke

  2008cited by this paper
• Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration

  2008influential reference
• Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease

  2008influential reference
• Perispinal etanercept: Potential as an Alzheimer therapeutic

  2008cited by this paper
• Perispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanism.

  2008cited by this paper
• Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice

  2008cited by this paper
• Effect of Etanercept, a Tumor Necrosis Factor-Alpha Inhibitor, on Neuropathic Pain in the Rat Chronic Constriction Injury Model

  2008cited by this paper
• Dysphagia in acute ischaemic stroke: severity, recovery and relationship to stroke subtype.

  2007cited by this paper
• The Montreal Cognitive Assessment: Validity and Utility in a Memory Clinic Setting

  2007influential reference
• Perispinal etanercept for treatment of Alzheimer's disease.

  2007influential reference
• Cognitive function, gait speed decline, and comorbidities: the health, aging and body composition study.

  2007cited by this paper
• TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets.

  2007cited by this paper
• How TNF was recognized as a key mechanism of disease.

  2007cited by this paper
• The tripartite synapse: roles for gliotransmission in health and disease.

  2007cited by this paper
• Glia: they make your memories stick!

  2007cited by this paper
• When are randomised trials unnecessary? Picking signal from noise

  2007cited by this paper
• The Major Role of Clinicians in the Discovery of Off‐Label Drug Therapies

  2006cited by this paper
• Synaptic scaling mediated by glial TNF-α

  2006cited by this paper
• Immunomodulatory Effects of Etanercept in an Experimental Model of Spinal Cord Injury

  2006cited by this paper
• The Craniospinal Venous System

  2006cited by this paper
• Intrinsic Activated Microglia Map to the Peri-infarct Zone in the Subacute Phase of Ischemic Stroke

  2006cited by this paper
• The cerebrospinal venous system: anatomy, physiology, and clinical implications.

  2006cited by this paper
• TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study.

  2006influential reference

• TNF-α in traumatic brain injury: a bidirectional effect in regulating neuroimmune and inflammatory responses

  2025cites this paper
• Immunomodulation of microglia/macrophages and neutrophils as immunotherapeutic targets in ischemic stroke: A narrative review

  2025cites this paper
• Evaluating the Safety and Effectiveness of Perispinal Etanercept for Post-Stroke Recovery: A Systematic Review

  2025cites this paper
• Safety and Efficacy of Perispinal Etanercept for Chronic Stroke

  2025influential citation
• Modulation of Inflammatory Response by Electromagnetic Field Stimulation in Traumatic Brain Injury in Yucatan Swine

  2024cites this paper
• Perispinal Etanercept to improve STroke Outcomes (PESTO): Protocol for a multicenter, international, randomized placebo-controlled trial

  2024cites this paper
• Perispinal etanercept stroke trial design: PESTO and beyond

  2024influential citation
• An updated review on prediction and preventive treatment of post-stroke depression

  2023cites this paper
• Autocrine positive feedback of tumor necrosis factor from activated microglia proposed to be of widespread relevance in chronic neurological disease

  2023cites this paper
• Neuroinflammatory Biomarkers in the Brain, Cerebrospinal Fluid, and Blood After Ischemic Stroke

  2023cites this paper
• The efficacy and mechanism of Zhengan Xifeng Decoction in the treatment of ischemic stroke: a network pharmacology study

  2023cites this paper
• Etanercept alleviates psoriasis by reducing the Th17/Treg ratio and promoting M2 polarization of macrophages

  2022cites this paper
• Inflammatory Biomarkers of Traumatic Brain Injury

  2022cites this paper
• Inflammatory Responses After Ischemic Stroke

  2022cites this paper
• Tumor Necrosis Factor-α: The Next Marker of Stroke

  2022cites this paper
• Rapid improvement in severe long COVID following perispinal etanercept

  2022cites this paper
• Fetal and Perinatal Expression Profiles of Proinflammatory Cytokines in the Neuroplacodes of Rats with Myelomeningoceles: A Contribution to the Understanding of Secondary Spinal Cord Injury in Open Spinal Dysraphism

  2021cites this paper
• Role of innate inflammation in traumatic brain injury

  2021cites this paper
• Unravelling neuroinflammation in abusive head trauma with radiotracer imaging

  2021cites this paper
• TNF-α Receptor Inhibitor Alleviates Metabolic and Inflammatory Changes in a Rat Model of Ischemic Stroke

  2021cites this paper
• 3,6′-Dithiopomalidomide Ameliorates Hippocampal Neurodegeneration, Microgliosis and Astrogliosis and Improves Cognitive Behaviors in Rats with a Moderate Traumatic Brain Injury

  2021cites this paper
• Phase I/II parallel double-blind randomized controlled clinical trial of perispinal etanercept for chronic stroke: improved mobility and pain alleviation

  2020influential citation
• Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions

  2020cites this paper
• Characterization of the TNF and IL-1 systems in human brain and blood after ischemic stroke

  2020cites this paper
• Management of Traumatic Brain Injury: From Present to Future

  2020cites this paper
• Randomized controlled trial validating the use of perispinal etanercept to reduce post-stroke disability has wide-ranging implications

  2020cites this paper
• Background to new treatments for COVID‐19, including its chronicity, through altering elements of the cytokine storm

  2020cites this paper
• Neurodegenerative disease treatments by direct TNF reduction, SB623 cells, maraviroc and irisin and MCC950, from an inflammatory perspective – a Commentary

  2019cites this paper
• Cognitive Decline Secondary to Therapeutic Brain Radiation—Similarities and Differences to Traumatic Brain Injury

  2019cites this paper
• Metabolism and inflammation: implications for traumatic brain injury therapeutics

  2019cites this paper
• TBI Rehabilomics Research: Conceptualizing a humoral triad for designing effective rehabilitation interventions.

  2019cites this paper
• Immediate Resolution of Hemispatial Neglect and Central Post-Stroke Pain After Perispinal Etanercept: Case Report

  2019cites this paper
• Therapeutic Evaluation of Tumor Necrosis Factor-alpha Antagonist Etanercept against Traumatic Brain Injury in Rats: Ultrastructural, Pathological, and Biochemical Analyses

  2018influential citation
• Lowering Pathologic TNF Levels Exclusively Within the Brain Rapidly Alleviates Long-Standing Injury-Induced Neural Pathologies

  2018cites this paper
• The Inflammatory Nature of Post-surgical Delirium Predicts Benefit of Agents With Anti-TNF Effects, Such as Dexmedetomidine

  2018cites this paper
• Blood purification by nonselective hemoadsorption prevents death after traumatic brain injury and hemorrhagic shock in rats

  2018cites this paper
• Perispinal etanercept advances as a neurotherapeutic

  2018cites this paper
• Does atrial fibrillation cause cognitive decline and dementia?

  2018cites this paper
• Novel TNF receptor-1 inhibitors identified as potential therapeutic candidates for traumatic brain injury

  2018cites this paper
• Blocking Tumor Necrosis Factor-Alpha Expression Prevents Blast-Induced Excitatory/Inhibitory Synaptic Imbalance and Parvalbumin-Positive Interneuron Loss in the Hippocampus

  2018cites this paper
• Post-stroke inflammation—target or tool for therapy?

  2018cites this paper
• Microglial Activation in Traumatic Brain Injury

  2017cites this paper
• Therapeutic Antibody‐Based Drugs in the Treatment of Human Inflammatory Disorders

  2017cites this paper
• Perispinal Etanercept for Traumatic Brain Injury

  2017cites this paper
• Immunomodulatory and neuroprotective approaches including human mesenchymal precursor cell transplantation for spinal cord injury repair

  2017cites this paper
• On Overcoming Barriers to Application of Neuroinflammation Research

  2017cites this paper
• Efficacy and safety of Xinglouchengqi decoction for acute ischemic stroke with constipation: study protocol for a randomized controlled trial.

  2017cites this paper
• Role of aquaporin-4 in methamphetamine-induced blood-brain barrier dysfunction and cerebral edema formation

  2017cites this paper
• The impact of nutrition on neuroinflammation in vitro and in vivo

  2017cites this paper
• The meteorology of cytokine storms, and the clinical usefulness of this knowledge

  2017cites this paper
• The Polarization States of Microglia in TBI: A New Paradigm for Pharmacological Intervention

  2017cites this paper
• Early to Long-Term Alterations of CNS Barriers After Traumatic Brain Injury: Considerations for Drug Development

  2017cites this paper
• An unsound AAN Practice Advisory on poststroke etanercept

  2017cites this paper
• Attenuation of Myeloid-Specific TGF&bgr; Signaling Induces Inflammatory Cerebrovascular Disease and Stroke

  2017cites this paper
• Roles of Pro- and Anti-inflammatory Cytokines in Traumatic Brain Injury and Acute Ischemic Stroke

  2017cites this paper
• Sex differences in vascular physiology and pathophysiology: estrogen and androgen signaling in health and disease.

  2017cites this paper
• A monocyte‐TNF‐endothelial activation axis in sickle transgenic mice: Therapeutic benefit from TNF blockade

  2017cites this paper
• Progranulin protects against exaggerated axonal injury and astrogliosis following traumatic brain injury

  2017cites this paper
• 2. Barriers to translation of medical innovation

  2017influential citation
• Inhibition of Peripheral TNF-α and Downregulation of Microglial Activation by Alpha-Lipoic Acid and Etanercept Protect Rat Brain Against Ischemic Stroke

  2016cites this paper
• Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents

  2016cites this paper
• Practice advisory: Etanercept for poststroke disability

  2016cites this paper
• Perispinal Delivery of CNS Drugs

  2016cites this paper
• Bifunctional role of pro-inflammatory cytokines after traumatic brain injury

  2016cites this paper
• Therapies negating neuroinflammation after brain trauma.

  2016cites this paper
• Cognitive deficits develop 1month after diffuse brain injury and are exaggerated by microglia-associated reactivity to peripheral immune challenge.

  2016cites this paper
• Inflammatory cytokine receptor blockade in a rodent model of mild traumatic brain injury

  2016cites this paper
• Letter by Clark Regarding Article, "Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2a Study".

  2016cites this paper
• Tumor Necrosis Factor α as a Potential Mediator of the Effects of Phosphodiesterase 4B Inhibition on Cognition after Traumatic Brain Injury

  2016cites this paper
• Genetic ablation of soluble tumor necrosis factor with preservation of membrane tumor necrosis factor is associated with neuroprotection after focal cerebral ischemia

  2016cites this paper
• Role of Ion Channels and Activation State in Regulation of Podosomes, Migration and Invasion, and Phagocytosis in Microglia

  2016cites this paper
• Experimental treatments for poststroke disability

  2016cites this paper
• Treatment of traumatic brain injury with anti-inflammatory drugs.

  2016cites this paper
• Subventricular zone neural progenitors reverse TNF-alpha effects in cortical neurons

  2015cites this paper
• A Neurologist's Guide to TNF Biology and to the Principles behind the Therapeutic Removal of Excess TNF in Disease

  2015cites this paper
• Effects of systemic Thalidomide and intracerebroventricular Etanercept and Infliximab administration in a Streptozotocin induced dementia model in rats.

  2015cites this paper
• Transiently lowering tumor necrosis factor-α synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in mice

  2015cites this paper
• Amyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer’s disease

  2015cites this paper
• Developing drug strategies for the neuroprotective treatment of acute ischemic stroke

  2015cites this paper
• Post-trauma administration of the pifithrin-α oxygen analog improves histological and functional outcomes after experimental traumatic brain injury.

  2015cites this paper
• Supporting evidence for using Perispinal Etanercept to inhibit TNFα when treating neuropathologies including dementia, chronic stroke, neuropathic pain or traumatic brain injury: Clinical outcomes and role of TNF in neuropathologies other than Alzheimer’s Dementia (Part III)

  2015influential citation
• Pharmacological interventions for unilateral spatial neglect after stroke.

  2015cites this paper
• The TNF-α/Nf-κB Signaling Pathway has a Key Role in Methamphetamine–Induced Blood–Brain Barrier Dysfunction

  2015cites this paper
• Mincle Signaling in the Innate Immune Response after Traumatic Brain Injury

  2015cites this paper
• Targeting of Tumor Necrosis Factor Alpha Receptors as a Therapeutic Strategy for Neurodegenerative Disorders

  2015cites this paper
• Anti-inflammatory Strategies in Stroke: a Potential Therapeutic Target.

  2015cites this paper
• Biothérapies anti-TNF-α et douleur

  2015cites this paper
• The hippocampus and TNF: Common links between chronic pain and depression.

  2015cites this paper
• A novel caffeoyl triterpene attenuates cerebral ischemic injury with potent anti‐inflammatory and hypothermic effects

  2015cites this paper
• Alzheimer's Disease: Exploring the Role of Inflammation and Implications for Treatment

  2015cites this paper
• Inflammation-sleep interface in brain disease: TNF, insulin, orexin

  2014cites this paper
• Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence

  2014cites this paper
• Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date

  2014cites this paper
• Cerebral stroke injury: the role of cytokines and brain inflammation

  2014cites this paper
• Targeting TNF: a therapeutic strategy for Alzheimer's disease.

  2014cites this paper
• Expression levels of tumor necrosis factor-α and the corresponding receptors are correlated with trauma severity

  2014cites this paper
• δ-Opioid Receptors and Inflammatory Cytokines in Hypoxia: Differential Regulation Between Glial and Neuron-Like Cells

  2014cites this paper
• Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia

  2014cites this paper
• Immediate Neurological Recovery Following Perispinal Etanercept Years After Brain Injury

  2014influential citation
• Authors’ Reply to Whitlock: Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence

  2014influential citation